[Prevention of clot formation and improvement of blood rheological properties during microsurgical operations. Part II. Comparative studies of small doses of acelysin and low molecular weight heparin enoxaparine (clexane)].
Vabishchevich
A V
AV
Smirnova
L A
LA
Roĭtman
E V
EV
Fedotov
S A
SA
Shibaev
E Iu
EIu
Svetlov
V A
VA
D000328:Adult; D000768:Anesthesia, General; D000925:Anticoagulants / Q000008:administration & dosage / Q000627:therapeutic use*; D001241:Aspirin / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D001777:Blood Coagulation / Q000187:drug effects*; D001780:Blood Coagulation Tests; D004338:Drug Combinations; D017984:Enoxaparin / Q000008:administration & dosage / Q000627:therapeutic use; D005998:Glycine / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D007431:Intraoperative Complications; D008239:Lysine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D008866:Microsurgery / Q000379:methods*; D008875:Middle Aged; D016343:Monitoring, Intraoperative; D012212:Rheology; D013927:Thrombosis / Q000209:etiology / Q000517:prevention & control*
D000925:Anticoagulants; D004338:Drug Combinations; D017984:Enoxaparin; C076488:acetylsalicylate, glycine, lysine drug combination; D008239:Lysine; D001241:Aspirin; D005998:Glycine